| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. (ARWR) has 12 insiders with recent SEC Form 4 filings, including 8 buys and 31 sells. ARWR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $311.00M | - | |
| COO | 473.3K | $38.81M | - | |
| Other | 227.0K | $18.61M | - | |
| CFO | 162.9K | $13.36M | - | |
| Dir | 123.1K | $10.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2020 | Anzalone Christopher Richard60 | Chief Executive Officer | Sale+OE | 50,000 | $41.35 | $2,067,500.00 | -1.9% | |
| Jun 25, 2020 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 100,000 | $38.81 | $3,881,017.02 | -1.9% | |
| Jun 15, 2020 | De Backer Marianne65 | Director | Buy | 4,000 | $33.56 | $134,240.00 | +3.5% | |
| May 12, 2020 | Perry Michael S55 | Director | Sell | 36,000 | $35.83 | $1,289,891.00 | -62.0% | |
| May 11, 2020 | Waddill William D.50 | Director | Sell | 26,000 | $36.54 | $950,040.00 | -48.1% | |
| Apr 28, 2020 | Given Bruce D | Chief Operating Officer | Sale+OE | 5,401 | $40.00 | $216,040.00 | - | |
| Apr 20, 2020 | Given Bruce D | Chief Operating Officer | Sale+OE | 23,515 | $40.00 | $940,600.00 | -0.5% | |
| Apr 14, 2020 | Given Douglas B66 | Director | Sell | 25,000 | $36.89 | $922,250.00 | -13.8% | |
| Jan 21, 2020 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sale+OE | 40,313 | $49.44 | $1,992,924.63 | -1.7% | |
| Jan 6, 2020 | O'Brien Patrick76 | General Counsel | Sell | 14,625 | $60.12 | $879,260.67 | -1.8% |